We studied the sudomotor skin response (SSR) in patients with Parkinson's disease with and without symptomatic hyperhidrosis. The study was carried out in 13 patients who complained of excessive sweating and in 37 patients who did not have excessive sweating. Patients were matched for age, sex, degree of impairment, duration of the disease, and number and severity of autonomic disturbances. Excessive sweating involved mainly the face, head, and trunk. The SSR was recorded from the palm of the hands to electrical stimulation of the median nerve at the wrist. We analyzed onset latency, peak to peak amplitude, and waveform. 
Hyperhidrosis is a frequent nonmotor complaint of patients with Parkinson's disease 1, 2 (PD) that may reveal autonomic dysfunction. 3, 4 One of the simplest tests used in the evaluation of sweating disturbances is the sympathetic sudomotor skin reflex response (SSR), a noninvasive recording of the galvanic potential of the skin. [5] [6] [7] The SSR has been studied in patients with idiopathic PD (IPD), and the abnormalities found have been interpreted as a sign of autonomic dysfunction. 8 -10 However, these studies have not specifically addressed the possible relationship between SSR abnormalities and sweating disturbances. Knowing that patients with hyperhidrosis are likely to exhibit SSR abnormalities, 11, 12 we decided to study the characteristics of the SSR in patients with IPD and sweating complaints.
SUBJECTS AND METHODS
The study was performed in patients with probable IPD, diagnosed according to standard criteria. 13 As part of a more complete questionnaire for autonomic disturbances, patients were requested to answer "yes" or "no" to the following question: "Have you experienced problems with sweating?" In the case of an affirmative response, we specifically asked, "Are these problems due to excessive sweating or lack of sweating," and "In what region of your body do you experience the problems with sweating?" We did not specifically ask for the possible relationship between signs of autonomic dysfunction and medication-related fluctuations.
Selection Criteria
We excluded from the study patients with clinical signs suggesting non-IPD Parkinsonism, coincidental diseases potentially involving the autonomic nervous system, or use of drugs known to influence autonomic function. Selected patients were scheduled for a conventional electrophysiological testing of nerve conduction, and those who had electrophysiological signs suggesting polyneuropathy 14 were also excluded. For comparison, we studied a group of 54 healthy control subjects of the same age range. All patients and controls gave their informed consent for the study, which was approved by the Ethical Committee of the Hospital de Clínicas of Porto Alegre.
Procedure
Selected patients were examined after discontinuation of all antiparkinsonian medications for 14 hours. The SSR was examined in both hands using conventional methods 6 by an examiner blinded to the results of the questionnaire, using a Medelec Synergy electromyograph. The active surface electrode was placed on the palm and the reference electrode on the dorsum of the hand. Responses were recorded in a time window of 10 seconds, a gain of 0.2 to 1.0 mV, and a band pass frequency filter of 0.1 Hz to 0.5 KHz. Electrical stimuli of 30 mA intensity were delivered to the median nerve. Five stimuli were applied, with a minimum interval of 30 seconds between stimuli. We measured the peak-to-peak amplitude and onset latency of the response with the largest amplitude. Absent responses were considered when no consistent change in the baseline larger than 50 V was observed in the 2 seconds following the stimulus in any one of the recordings. We classified the SSR waveforms according to Toyokura and Takeda: 15 "N type" were those with only or predominantly negativegoing oscillation, "P type" were those with only or predominantly positive-going oscillation, and "M type" were those with negative-positive oscillations of similar amplitude. Figure 1 shows an example of each type of waveform, recorded from different individuals. An SSR waveform type (N, P, or M) was assigned to each individual and site of recording according to the predominant waveform among the five responses obtained in each site.
Statistical Analysis
Patients were divided into groups according to whether they reported excessive sweating, lack of sweating, or no sweating disturbances. The mean and standard deviation were calculated for the amplitude and latency of the SSRs in the three groups of patients. A paired t test was performed to compare data obtained in both hands from the same individuals. ANOVA was used for comparison of amplitude and latency of the SSR between healthy controls and groups of patients. When differences were found, a post hoc analysis was done using the Bonferroni's test. Categorical variables were analyzed using a 2 test. A value of P Ͻ 0.05 was considered to indicate statistical significance. 
RESULTS
Of 50 consecutive patients, 13 reported problems with sweating. All complained of excessive sweating and reported that this phenomenon occurred in their face, head, or trunk. None of them complained of excessive sweating in extremities or in another body region. At the time of the examination, no patient exhibited significant motor oscillations or paroxysmal dyskinesia that could interfere with the results obtained in the SSR.
There were no significant differences between IPD patients and control subjects with regard to age (P ϭ 0.434), sex distribution (P ϭ 0.127), weight (P ϭ 0.171), and height (P ϭ 0.205). There were no statistically significant differences between IPD patients with excessive sweating and with no sweating disturbances regarding demographic data, parkinsonian features, the use of antiparkinsonian medication (Table  1) , or the symptoms and signs suggesting disorders of autonomic functions other than sweating disturbances (Table 2) . Also, there were no significant differences regarding the results obtained from nerve conduction studies, reported in Table 3 for control subjects and both groups of patients.
There were no statistically significant differences between data on onset latency or amplitude measured in the SSRs recorded in both hands for each group of subjects (paired Student's t test; P ϭ 0.818 for latency; P ϭ 0.371 for amplitude). Therefore, we averaged the data on SSR latency and amplitude from both hands for each group of subjects. When comparing data between control subjects, patients with excessive sweating and patients who did not report sweating disorders, significant differences were found in the amplitude of the SSR (ANOVA; F[2,101] ϭ 11.678; P Ͻ 0.001) but not in their latency (F[2,101] ϭ 1.637; P ϭ 1.00). The post hoc analysis on amplitude of the SSR showed significant differences in all paired comparisons, with lower amplitude SSR in patients with excessive sweating than in the two other groups, and lower amplitude SSR in patients with no sweating disturbances than in control subjects (Fig. 2) . Regarding the SSR waveform (Table 4) , IPD patients with excessive sweating showed a statistically significant higher percentage of absent responses ( 2 ϭ 5.292; P ϭ 0.021) and a lower percentage of monophasic type N pattern ( 2 ϭ 8.493; P ϭ 0.004), in comparison to patients who did not report sweating disturbances. There were no significant differences in the prevalence of M-type ( 2 ϭ 0.372; P ϭ 0.542) or P-type patterns ( 2 ϭ 0.292; P ϭ 0.589) between groups.
DISCUSSION
Our finding of absent or abnormally reduced amplitude SSRs in a percentage of patients with IPD is in agreement with previous reports. 4,8 -10 The peculiarity of our finding is that abnormalities in the SSR were more marked in patients who complained of hyperhidrosis than in patients who did not have such a complaint. The percentage of PD patients with hyperhidrosis in our study is smaller than that reported in the literature. 1 One possible explanation is that our patients were relatively less affected by the disease, with lower Hoehn & Yahr scores and shorter disease duration, than those reported by Swinn and colleagues. 1 Another difference between our study and that of Swinn and associates 1 is that, in our patients, hyperhidrosis did not correlate with the presence of other autonomic symptoms. In fact, however, sympathetic denervation in IPD is known to be heterogeneous among different body organs, 16 and distinct types of sympathetic fibers may have a different degree of involvement. 17 Amino and coworkers 18 have reported a profound sympathetic denervation of the heart, attributed to loss of sympathetic neurons.
At first glance, the finding of abnormally reduced or absent SSR would seem in contrast with the patients complaint of excessive sweating. However, it is relevant to point out that excessive sweating in our patients did not affect extremities, but did affect the face, head, and trunk. Hyperhidrosis in axial body parts could be the expression of a compensatory mechanism for a defective sudomotor outflow in hands and feet as it has been reported in patients with peripheral neuropathy or central nervous system lesions causing sympathetic dysfunction. 19 -22 Our patients did not have clinical or electrophysiological signs of peripheral neuropathy, but our study does not completely rule out the possibility of small fiber neuropathy.
The analysis of the SSR waveform may bring further information on the characteristics of the sympathetic dysfunction. Apart from the higher prevalence of absent responses, our IPD patients with excessive sweating had a lower prevalence of N type response waveforms. According to Toyokura and Takeda 15 and Mitani and colleagues, 23 the negative component of the SSR is generated by the electrical dipole created in the gland ductus by sodium re-entry, whereas the positive component originates from the inversion of the dipole after sweat release. Therefore, the presence of an N type waveform should indicate integrity of cholinergic sympathetic activation, and its lower prevalence in PD patients who complained of hyperhidrosis, is likely to point to a diminished cholinergic innervation of their sweat glands.
In conclusion, our study shows that IPD patients with hyperhidrosis of the face, head, and trunk have more marked abnormalities of the SSR than IPD patients who do not complain of hyperhidrosis. This finding is in agreement with the notion of a compensatory sympathetic sweating disorder. The analysis of the SSR waveform contributes to the characterization of sudomotor disturbances in patients with PD. 
